Safety of (4-Methoxyphenyl)methanol. Recently I am researching about MANNOSE-BINDING LECTIN; IMMUNE COMPONENT FICOLIN-3; ALL-CAUSE MORTALITY; VASCULAR COMPLICATIONS; COMPLEMENT; ASSOCIATION; MICROALBUMINURIA; POPULATION; DEFICIENCY; SEVERITY, Saw an article supported by the Danish Diabetes Association; Danish Council for Independent ResearchDet Frie Forskningsrad (DFF); Health Research Fund of Central Denmark Region; Folkhalsan Research Foundation; Academy of FinlandAcademy of FinlandEuropean Commission [316664, 299200]; Wilhelm and Else Stockmann Foundation; Novo Nordisk FoundationNovo Nordisk Foundation [OC0013659]; Paivikki and Sakari Sohlberg Foundation; Medical Society of Finland; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Karl Walter and Jarl Walter Perklen Foundation; Dorothea Olivia; HUH state research funding (EVO governmental grant) [TYH2018207]; Liv och Halsa Society. Published in NATURE RESEARCH in BERLIN ,Authors: Ostergaard, JA; Sigfrids, FJ; Forsblom, C; Dahlstrom, EH; Thorn, LM; Harjutsalo, V; Flyvbjerg, A; Thiel, S; Hansen, TK; Groop, PH. The CAS is 105-13-5. Through research, I have a further understanding and discovery of (4-Methoxyphenyl)methanol
H-ficolin recognizes patterns on microorganisms and stressed cells and can activate the lectin pathway of the complement system. We aimed to assess H-ficolin in relation to the progression of diabetic kidney disease (DKD), all-cause mortality, diabetes-related mortality, and cardiovascular events. Event rates per 10-unit H-ficolin-increase were compared in an observational follow-up of 2,410 individuals with type 1 diabetes from the FinnDiane Study. DKD progression occurred in 400 individuals. The unadjusted hazard ratio (HR) for progression was 1.29 (1.18-1.40) and 1.16 (1.05-1.29) after adjustment for diabetes duration, sex, HbA(1c), systolic blood pressure, and smoking status. After adding triglycerides to the model, the HR decreased to 1.07 (0.97-1.18). In all, 486 individuals died, including 268 deaths of cardiovascular causes and 192 deaths of complications to diabetes. HRs for all-cause mortality and cardiovascular mortality were 1.13 (1.04-1.22) and 1.05 (0.93-1.17), respectively, in unadjusted analyses. These estimates lost statistical significance in adjusted models. However, the unadjusted HR for diabetes-related mortality was 1.19 (1.05-1.35) and 1.18 (1.02-1.37) with the most stringent adjustment level. Our results, therefore, indicate that H-ficolin predicts diabetes-related mortality, but neither all-cause mortality nor fatal/non-fatal cardiovascular events. Furthermore, H-ficolin is associated with DKD progression, however, not independently of the fully adjusted model.
Safety of (4-Methoxyphenyl)methanol. About (4-Methoxyphenyl)methanol, If you have any questions, you can contact Ostergaard, JA; Sigfrids, FJ; Forsblom, C; Dahlstrom, EH; Thorn, LM; Harjutsalo, V; Flyvbjerg, A; Thiel, S; Hansen, TK; Groop, PH or concate me.
Reference:
Alcohol – Wikipedia,
,Alcohols – Chemistry LibreTexts